Publication: Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion
No Thumbnail Available
Date
1999-08-13
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Cherny, Robert A., Jacinta T. Legg, Catriona A. McLean, David P. Fairlie, Xudong Huang, Craig S. Atwood, Konrad Beyreuther et al. "Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion." Journal of Biological Chemistry 274, no. 33 (1999): 23223-23228. DOI: 10.1074/jbc.274.33.23223
Research Data
Abstract
Zn(II) and Cu(II) precipitate Aβ in vitro into insoluble aggregates that are dissolved by metal chelators. We now report evidence that these biometals also mediate the deposition of Aβ amyloid in Alzheimer’s disease, since the solubilization of Aβ from post-mortem brain tissue was significantly increased by the presence of chelators, EGTA, N,N,N',N'-tetrakis(2-pyridyl-methyl) ethylene diamine, and bathocuproine. Efficient extraction of Aβ also required Mg(II) and Ca(II). The chelators were more effective in extracting Aβ from Alzheimer’s disease brain tissue than age-matched controls, suggest- ing that metal ions differentiate the chemical architec- ture of amyloid in Alzheimer’s disease. Agents that specifically chelate copper and zinc ions but preserve Mg(II) and Ca(II) may be of therapeutic value in Alzheimer’s disease.
Description
Other Available Sources
Keywords
Cell Biology, Molecular Biology, Biochemistry
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service